Trial Profile
A Double-masked Study of DE-111 Ophthalmic Solution Versus Timolol Ophthalmic Solution 0.5% in Patients With Primary Open Angle Glaucoma or Ocular Hypertension - Phase 3, Confirmatory Study -
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 15 Jul 2015
Price :
$35
*
At a glance
- Drugs Tafluprost/timolol (Primary) ; Timolol
- Indications Ocular hypertension; Open-angle glaucoma
- Focus Registrational; Therapeutic Use
- Sponsors Santen Pharmaceutical
- 25 Apr 2014 New trial record